Karen Langhart never thought she would outlive her daughter. However, due to insufficient drug testing and inadequate medical warnings, NuvaRing caused blood clots, pulmonary embolisms and heart attacks resulting in…
Read More
Women who experienced Yaz side effects involving certain types of blood clot formation, and who filed lawsuits against Yaz and Yasmin manufacturer, Bayer, received good news last month. The federal…
Read More
The Langhart parents were expecting their daughter, Erika, to fly home for Thanksgiving. Instead, they got a call summoning them to a Virginia hospital, because their daughter had suffered multiple…
Read More
According to an article recently published in The Vancouver Sun, the birth control pills Yaz and Yasmin, manufactured by Bayer, have been linked to the deaths of 23 women in…
Read More
August 15, 2009 – Boehringer Ingelheim researchers submitted Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial data to The New England Journal of Medicine October 19, 2010 – Pradaxa approved…
Read More
The NuvaRing mass tort in New Jersey recently convened on June 19, 2013 for a case management conference amid news that the first NuvaRing lawsuit consolidated into the mass tort…
Read More
According to a recent Madison-St. Clair Record article, NuvaRing lawsuits have recently been filed in the U.S. District Court for the Southern District of Illinois charging five defendants, among them…
Read More
The U.S. Food and Drug Administration (FDA) recently approved a reversal agent to be used in patients experiencing serious and uncontrollable bleeding. The anticoagulation reversal agent is called Kcentra, a…
Read More
The blood thinner medication known as Pradaxa is currently under scrutiny, as the drug has been known to cause severe bleeding, sometimes resulting in death. Pradaxa is a drug manufactured…
Read More
Bayer was recently dealt a setback in a Federal Court of Appeals in Washington. Their patent on Yaz, a contraceptive pill, was deemed to no longer be worthy of patent…
Read More